Angebotsfrist
19. Nov 2026, 12:00
Geschätzter Wert
375.000 EUR
CPV-Code
38000000
NUTS-Region
IE061
Zweck
The Cancer Molecular Diagnostics laboratory provides a range of molecular diagnostic tests for the diagnosis and management of haematological and solid malignancy. Currently this testing is divided among standard PCR, real-time PCR and Next Generation Sequencing (NGS) based diagnostics. While the laboratory is developing NGS based testing methodologies it is also seeking to secure access to reagents and consumables to continue to provide legacy clonality testing using capillary electrophoresis.
Lose 1 Los
Invitation to tender for the provision of Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
The Cancer Molecular Diagnostics laboratory provides a range of molecular diagnostic tests for the diagnosis and management of haematological and solid malignancy. Currently this testing is divided among standard PCR, real-time PCR and Next Generation Sequencing (NGS) based diagnostics. While the laboratory is developing NGS based testing methodologies it is also seeking to secure access to reagents and consumables to continue to provide legacy clonality testing using capillary electrophoresis.
- CPV-Code
- 38000000
- Angebotsfrist
- 19. Nov 2026, 12:00
- Geschätzter Wert
- 375.000 EUR